Mental Health DailyResearch. Evidence. Perspective.Published research on cymbalta.
It appears as though the pharmaceutical juggernaut Eli Lilly is facing major legal backlash for failure to disclose discontinuation effects associated with their medication Cymbalta (Duloxet…
Read articleCymbalta (Duloxetine) is a drug that us utilized primarily to treat major depression. It was approved in 2004 by the FDA as an SNRI antidepressant, and would later receive approval for the t…
Read articleIf you have major depression, chances are good that you could name a few common antidepressants off the top of your head. When most people think of antidepressants, they think of the current…
Read articleThe popularity of antidepressants has changed significantly over time. The first antidepressants called MAOIs were discovered in the 1950s and instantly became the most popular class. As new…
Read articleSNRIs (Selective Serotonin Reuptake Inhibitors) are also known as dual-reuptake inhibitors because they prevent the reuptake of multiple neurotransmitters in the brain. Most of the second-ge…
Read articleResearch firm IMS Health has been collecting data on the number of prescriptions filled for certain drugs as well as the top selling drugs. The data that they collected was from July 2013 to…
Read articleA newly released report from research firm IMS Health collected data on the most prescribed drugs in the United States from June 2013 to July 2014. Although the number one drug was Synthroid…
Read article